Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Interleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis.

Martin NM, Griffin DE.

J Virol. 2018 Feb 26;92(6). pii: e01517-17. doi: 10.1128/JVI.01517-17. Print 2018 Mar 15.

PMID:
29263262
2.

Deubiquitylating enzymes and drug discovery: emerging opportunities.

Harrigan JA, Jacq X, Martin NM, Jackson SP.

Nat Rev Drug Discov. 2018 Jan;17(1):57-78. doi: 10.1038/nrd.2017.152. Epub 2017 Sep 29. Review.

PMID:
28959952
3.

Time course analysis of RNA quality in placenta preserved by RNAlater or flash freezing.

Martin NM, Cooke KM, Radford CC, Perley LE, Silasi M, Flannery CA.

Am J Reprod Immunol. 2017 Apr;77(4). doi: 10.1111/aji.12637. Epub 2017 Jan 31.

4.

A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline.

Drake WM, Stiles CE, Bevan JS, Karavitaki N, Trainer PJ, Rees DA, Richardson TI, Baldeweg SE, Stojanovic N, Murray RD, Toogood AA, Martin NM, Vaidya B, Han TS, Steeds RP; UK Cabergoline valvulopathy study group, Baldeweg FC, Sheikh UE, Kyriakakis N, Parasuraman SK, Taylor L, Butt N, Anyiam S.

J Clin Endocrinol Metab. 2016 Nov;101(11):4189-4194. Epub 2016 Aug 29.

PMID:
27571182
5.

The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models.

Oplustil O'Connor L, Rulten SL, Cranston AN, Odedra R, Brown H, Jaspers JE, Jones L, Knights C, Evers B, Ting A, Bradbury RH, Pajic M, Rottenberg S, Jonkers J, Rudge D, Martin NM, Caldecott KW, Lau A, O'Connor MJ.

Cancer Res. 2016 Oct 15;76(20):6084-6094. Epub 2016 Aug 22.

6.

ASHP Statement on the Roles of Pharmacy Technicians.

Schultz JM, Jeter CK, Martin NM, Mundy TK, Reichard JS, Van Cura JD.

Am J Health Syst Pharm. 2016 Jun 15;73(12):928-30. doi: 10.2146/ajhp151014. No abstract available.

PMID:
27261243
7.

Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively.

Sam AH, Shah S, Saleh K, Joshi J, Roncaroli F, Robinson S, Cox J, Martin NM, Mendoza N, Meeran K, Mehta A, Dhillo WS.

Clin Endocrinol (Oxf). 2015 Dec;83(6):861-5. doi: 10.1111/cen.12860. Epub 2015 Aug 12.

PMID:
26201671
8.

Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.

Ramachandran R, Bech P, Murphy KG, Caplin ME, Patel M, Vohra S, Khan MS, Dhillo WS, Sharma R, Palazzo FF, Win Z, Tan T, Khoo B, Meeran K, Frilling A, Ghatei MA, Bloom SR, Martin NM.

J Clin Endocrinol Metab. 2015 Apr;100(4):1520-8. doi: 10.1210/jc.2014-3640. Epub 2015 Feb 9.

9.

Species-specific enzymatic tolerance of sulfide toxicity in plant roots.

Martin NM, Maricle BR.

Plant Physiol Biochem. 2015 Mar;88:36-41. doi: 10.1016/j.plaphy.2015.01.007. Epub 2015 Jan 23.

10.

L-cysteine suppresses ghrelin and reduces appetite in rodents and humans.

McGavigan AK, O'Hara HC, Amin A, Kinsey-Jones J, Spreckley E, Alamshah A, Agahi A, Banks K, France R, Hyberg G, Wong C, Bewick GA, Gardiner JV, Lehmann A, Martin NM, Ghatei MA, Bloom SR, Murphy KG.

Int J Obes (Lond). 2015 Mar;39(3):447-55. doi: 10.1038/ijo.2014.172. Epub 2014 Sep 15.

11.

Effects of non-local exchange on core level shifts for gas-phase and adsorbed molecules.

Van den Bossche M, Martin NM, Gustafson J, Hakanoglu C, Weaver JF, Lundgren E, Grönbeck H.

J Chem Phys. 2014 Jul 21;141(3):034706. doi: 10.1063/1.4889919.

PMID:
25053333
12.

A high pressure x-ray photoelectron spectroscopy study of CO oxidation over Rh(100).

Gustafson J, Blomberg S, Martin NM, Fernandes V, Borg A, Liu Z, Chang R, Lundgren E.

J Phys Condens Matter. 2014 Feb 5;26(5):055003. doi: 10.1088/0953-8984/26/5/055003. Epub 2013 Dec 12.

PMID:
24334623
13.

Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans.

Petrie EC, Cross DJ, Yarnykh VL, Richards T, Martin NM, Pagulayan K, Hoff D, Hart K, Mayer C, Tarabochia M, Raskind MA, Minoshima S, Peskind ER.

J Neurotrauma. 2014 Mar 1;31(5):425-36. doi: 10.1089/neu.2013.2952.

14.

The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia.

Bech PR, Martin NM, Ramachandran R, Bloom SR.

Ann Clin Biochem. 2014 Jan;51(Pt 1):8-21. doi: 10.1177/0004563213489670. Epub 2013 Aug 12.

PMID:
23939195
15.

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.

Caino MC, Chae YC, Vaira V, Ferrero S, Nosotti M, Martin NM, Weeraratna A, O'Connell M, Jernigan D, Fatatis A, Languino LR, Bosari S, Altieri DC.

J Clin Invest. 2013 Jul;123(7):2907-20. doi: 10.1172/JCI67841. Epub 2013 Jun 10.

16.

Hepcidin levels in diabetes mellitus and polycystic ovary syndrome.

Sam AH, Busbridge M, Amin A, Webber L, White D, Franks S, Martin NM, Sleeth M, Ismail NA, Daud NM, Papamargaritis D, Le Roux CW, Chapman RS, Frost G, Bloom SR, Murphy KG.

Diabet Med. 2013 Dec;30(12):1495-9. doi: 10.1111/dme.12262. Epub 2013 Aug 19.

17.

Deubiquitylating enzymes and DNA damage response pathways.

Jacq X, Kemp M, Martin NM, Jackson SP.

Cell Biochem Biophys. 2013 Sep;67(1):25-43. doi: 10.1007/s12013-013-9635-3. Review.

18.

Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.

Batey MA, Zhao Y, Kyle S, Richardson C, Slade A, Martin NM, Lau A, Newell DR, Curtin NJ.

Mol Cancer Ther. 2013 Jun;12(6):959-67. doi: 10.1158/1535-7163.MCT-12-0707. Epub 2013 Mar 19.

19.

In situ x-ray photoelectron spectroscopy of model catalysts: at the edge of the gap.

Blomberg S, Hoffmann MJ, Gustafson J, Martin NM, Fernandes VR, Borg A, Liu Z, Chang R, Matera S, Reuter K, Lundgren E.

Phys Rev Lett. 2013 Mar 15;110(11):117601. Epub 2013 Mar 12.

PMID:
25166577
20.

Regulation of lung cancer metastasis by Klf4-Numb-like signaling.

Vaira V, Faversani A, Martin NM, Garlick DS, Ferrero S, Nosotti M, Kissil JL, Bosari S, Altieri DC.

Cancer Res. 2013 Apr 15;73(8):2695-705. doi: 10.1158/0008-5472.CAN-12-4232. Epub 2013 Feb 25.

21.

Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014.

Pike KG, Malagu K, Hummersone MG, Menear KA, Duggan HM, Gomez S, Martin NM, Ruston L, Pass SL, Pass M.

Bioorg Med Chem Lett. 2013 Mar 1;23(5):1212-6. doi: 10.1016/j.bmcl.2013.01.019. Epub 2013 Jan 18.

PMID:
23375793
22.

Skin closure after trauma laparotomy in high-risk patients: opening opportunities for improvement.

Seamon MJ, Smith BP, Capano-Wehrle L, Fakhro A, Fox N, Goldberg M, Martin NM, Pathak AS, Ross SE.

J Trauma Acute Care Surg. 2013 Feb;74(2):433-9; discussion 439-40. doi: 10.1097/TA.0b013e31827e2589. Erratum in: J Trauma Acute Care Surg. 2013 Jul;75(1):185.

PMID:
23354235
23.

Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.

Parker JA, McCullough KA, Field BC, Minnion JS, Martin NM, Ghatei MA, Bloom SR.

Int J Obes (Lond). 2013 Oct;37(10):1391-8. doi: 10.1038/ijo.2012.227. Epub 2013 Jan 22.

PMID:
23337772
24.

Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility.

Tavecchio M, Lisanti S, Lam A, Ghosh JC, Martin NM, O'Connell M, Weeraratna AT, Kossenkov AV, Showe LC, Altieri DC.

J Biol Chem. 2013 Feb 22;288(8):5553-61. doi: 10.1074/jbc.M112.433045. Epub 2013 Jan 9.

25.

Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.

Jaspers JE, Kersbergen A, Boon U, Sol W, van Deemter L, Zander SA, Drost R, Wientjens E, Ji J, Aly A, Doroshow JH, Cranston A, Martin NM, Lau A, O'Connor MJ, Ganesan S, Borst P, Jonkers J, Rottenberg S.

Cancer Discov. 2013 Jan;3(1):68-81. doi: 10.1158/2159-8290.CD-12-0049. Epub 2012 Oct 25.

26.

Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism.

Cegla J, Jones B, Seyani L, Papadoulou D, Wynne K, Martin NM, Meeran K, Chapman R, Donaldson M, Goldstone AP, Tan T.

Clin Endocrinol (Oxf). 2013 May;78(5):738-42. doi: 10.1111/cen.12043.

PMID:
22998100
27.

Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K.

Munck JM, Batey MA, Zhao Y, Jenkins H, Richardson CJ, Cano C, Tavecchio M, Barbeau J, Bardos J, Cornell L, Griffin RJ, Menear K, Slade A, Thommes P, Martin NM, Newell DR, Smith GC, Curtin NJ.

Mol Cancer Ther. 2012 Aug;11(8):1789-98. doi: 10.1158/1535-7163.MCT-11-0535. Epub 2012 May 10.

28.

A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.

Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, Dhillo W, Meeran K, Goldstone AP, Martin NM, Todd JF, Palazzo F, Tan T.

Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1266-70. doi: 10.1007/s00259-012-2119-7. Epub 2012 Apr 20.

PMID:
22526961
29.

Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.

Martin NM, Patel M, Nijher GM, Misra S, Murphy E, Meeran K.

Clin Endocrinol (Oxf). 2012 Oct;77(4):621-7. doi: 10.1111/j.1365-2265.2012.04385.x.

PMID:
22443227
30.

The Active Phase of Palladium during Methane Oxidation.

Hellman A, Resta A, Martin NM, Gustafson J, Trinchero A, Carlsson PA, Balmes O, Felici R, van Rijn R, Frenken JW, Andersen JN, Lundgren E, Grönbeck H.

J Phys Chem Lett. 2012 Mar 15;3(6):678-82. doi: 10.1021/jz300069s. Epub 2012 Feb 23.

PMID:
26286272
31.

Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.

Bech PR, Ramachandran R, Dhillo WS, Martin NM, Bloom SR.

Clin Chem. 2012 May;58(5):941-3. doi: 10.1373/clinchem.2011.176099. Epub 2012 Feb 23. No abstract available.

32.

Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial.

Higham CE, Atkinson AB, Aylwin S, Bidlingmaier M, Drake WM, Lewis A, Martin NM, Moyes V, Newell-Price J, Trainer PJ.

J Clin Endocrinol Metab. 2012 Apr;97(4):1187-93. doi: 10.1210/jc.2011-2603. Epub 2012 Jan 25.

PMID:
22278424
33.

Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays.

Ramachandran R, Bech P, Murphy KG, Dhillo WS, Meeran KM, Chapman RS, Caplin M, Ghatei MA, Bloom SR, Martin NM.

Clin Endocrinol (Oxf). 2012 Jun;76(6):831-6. doi: 10.1111/j.1365-2265.2011.04319.x.

PMID:
22175276
34.

Essential role of the small GTPase Ran in postnatal pancreatic islet development.

Xia F, Dohi T, Martin NM, Raskett CM, Liu Q, Altieri DC.

PLoS One. 2011;6(11):e27879. doi: 10.1371/journal.pone.0027879. Epub 2011 Nov 17.

35.

Post-mortem findings in 54 cases of anesthetic associated death in cats from two spay-neuter programs in New York State.

Gerdin JA, Slater MR, Makolinski KV, Looney AL, Appel LD, Martin NM, McDonough SP.

J Feline Med Surg. 2011 Dec;13(12):959-66. doi: 10.1016/j.jfms.2011.07.021. Epub 2011 Sep 9.

PMID:
21907603
36.

Stable cation inversion at the MgAl2O4(100) surface.

Rasmussen MK, Foster AS, Hinnemann B, Canova FF, Helveg S, Meinander K, Martin NM, Knudsen J, Vlad A, Lundgren E, Stierle A, Besenbacher F, Lauritsen JV.

Phys Rev Lett. 2011 Jul 15;107(3):036102. Epub 2011 Jul 13.

PMID:
21838378
37.

Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake.

Ghourab S, Beale KE, Semjonous NM, Simpson KA, Martin NM, Ghatei MA, Bloom SR, Smith KL.

Regul Pept. 2011 Dec 10;172(1-3):8-15. doi: 10.1016/j.regpep.2011.07.006. Epub 2011 Jul 28.

PMID:
21802451
38.

Progress in the function and regulation of ADP-Ribosylation.

Hottiger MO, Boothby M, Koch-Nolte F, Lüscher B, Martin NM, Plummer R, Wang ZQ, Ziegler M.

Sci Signal. 2011 May 24;4(174):mr5. doi: 10.1126/scisignal.2001645.

PMID:
21610250
39.

5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).

Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD.

J Med Chem. 2011 Apr 14;54(7):2049-59. doi: 10.1021/jm1010918. Epub 2011 Mar 18.

PMID:
21417348
40.

Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects.

Ford HE, Peters V, Martin NM, Sleeth ML, Ghatei MA, Frost GS, Bloom SR.

Eur J Clin Nutr. 2011 Apr;65(4):508-13. doi: 10.1038/ejcn.2010.291. Epub 2011 Jan 19.

PMID:
21245879
41.

Evaluation of a domain-specific anger expression assessment strategy.

Bongard S, Martin NM, Seip M, al'Absi M.

J Pers Assess. 2011 Jan;93(1):56-61. doi: 10.1080/00223891.2010.513705.

PMID:
21184331
42.

Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.

Sunderland PT, Dhami A, Mahon MF, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD.

Org Biomol Chem. 2011 Feb 7;9(3):881-91. doi: 10.1039/c0ob00665c. Epub 2010 Dec 2.

PMID:
21127791
43.

Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.

Tan T, Cabrita IZ, Hensman D, Grogono J, Dhillo WS, Baynes KC, Eliahoo J, Meeran K, Robinson S, Nihoyannopoulos P, Martin NM.

Clin Endocrinol (Oxf). 2010 Sep;73(3):369-74. doi: 10.1111/j.1365-2265.2010.03827.x. Epub 2010 Jun 9.

PMID:
20550538
44.

Dexamethasone-suppressed corticotrophin-releasing hormone-stimulation test does not reliably diagnose or predict recurrence of Cushing disease.

Salem V, Dhillo WS, Meeran K, Donaldson M, Martin NM.

Clin Chem. 2010 Jun;56(6):1031-4. doi: 10.1373/clinchem.2010.143263. Epub 2010 Apr 8. No abstract available.

45.

PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

Field BC, Wren AM, Peters V, Baynes KC, Martin NM, Patterson M, Alsaraf S, Amber V, Wynne K, Ghatei MA, Bloom SR.

Diabetes. 2010 Jul;59(7):1635-9. doi: 10.2337/db09-1859. Epub 2010 Mar 31.

46.

Need for revision of diagnostic limits for medullary thyroid carcinoma with a new immunochemiluminometric calcitonin assay.

Ramachandran R, Benfield P, Dhillo WS, White S, Chapman R, Meeran K, Donaldson M, Martin NM.

Clin Chem. 2009 Dec;55(12):2225-6. doi: 10.1373/clinchem.2009.129361. Epub 2009 Oct 15. No abstract available.

47.

Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR.

Menear KA, Gomez S, Malagu K, Bailey C, Blackburn K, Cockcroft XL, Ewen S, Fundo A, Le Gall A, Hermann G, Sebastian L, Sunose M, Presnot T, Torode E, Hickson I, Martin NM, Smith GC, Pike KG.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5898-901. doi: 10.1016/j.bmcl.2009.08.069. Epub 2009 Aug 21.

PMID:
19733066
48.

Two years of appropriateness criteria for echocardiography: what have we learned and what else do we need to do?

Martin NM, Picard MH.

J Am Soc Echocardiogr. 2009 Jul;22(7):800-2. doi: 10.1016/j.echo.2009.05.024. No abstract available.

PMID:
19560658
49.

Hypothalamic regulation of food intake and clinical therapeutic applications.

Simpson KA, Martin NM, Bloom SR.

Arq Bras Endocrinol Metabol. 2009 Mar;53(2):120-8. Review.

50.

Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin.

Hay T, Matthews JR, Pietzka L, Lau A, Cranston A, Nygren AO, Douglas-Jones A, Smith GC, Martin NM, O'Connor M, Clarke AR.

Cancer Res. 2009 May 1;69(9):3850-5. doi: 10.1158/0008-5472.CAN-08-2388. Epub 2009 Apr 21.

Supplemental Content

Loading ...
Support Center